Physicians’ Opinions Survey on FDA’s Bydureon Approval

Report Description

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Medical Composite Materials Market 2014-2018

Medical composite materials are formed by mixing two or more components. These materials offer greater performance than individual components. Some of the major benefits of medical composite materials are high strength-to-weight ratio, excellent fatigue endurance, corrosion resistance, good impact resistance, and malleability. As a result of these properties, the Medical sector prefers medical composite materials compared to steel, plastic, and aluminum for producing custom-made and complex products. TechNavio's analysts forecast the Global Medical Composite Materials market to grow at a CAGR of 6.84 percent over the period 2013-2018. Covered in this Report The Global Medical Composite Materials market can be segmented into three, based on type: fiber composites, polymer metal com......
$2500

Global Affinity Chromatography Reagents Market 2014-2018

Affinity chromatography is a method used in the examination of clinical samples with the help of high-performance liquid chromatography (HPLC) methods. Affinity chromatography is a liquid chromatography technique that helps purify and concentrate a substance from a mixture, and it also distinguishes what biological compounds bind to a particular substance. This technology is used by various end-users such as Biotechnology, Pharmaceutical, and Food and Beverages industries. TechNavio's analysts forecast the Global Affinity Chromatography Reagents market to grow at a CAGR of 9.27 percent over the period 2013-2018. Covered in this Report The report covers the present scenario and the growth prospects of the Global Affinity Chromatography Reagents market for the period 2014-2018. To c......
$2500

Global Proton Therapy Market 2014-2018

Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. Proton therapy uses the ionization technique to inhibit cell proliferation. Protons move slowly through the body and interact with electrons and discharge energy. The MD Anderson Proton Therapy Center is the pioneer in this technology and also initiated the pencil beam proton therapy, which is also known as scanning beam and intensity modulated proton therapy. TechNavio's analysts forecast the Global Proton Therapy market to grow at a CAGR of 9.50 percent over the period 2013-2018. Covered in this Report This report covers......
$2500

Connected Health M2M Market in the US 2014-2018

Connected health M2M is a remote healthcare service delivery model that functions in an IT ecosystem. It enables the accessing and sharing of healthcare information and the analysis of healthcare data. It provides the management of clinical data, and communication and collaboration among all the stakeholders of the healthcare service ecosystem. Some of the major functions of connected health M2M services are the following: home monitoring, clinical monitoring, telemedicine, first responder connectivity, connected medical environment, clinical remote monitoring, assisted living and clinical trials, and healthcare asset management. TechNavio's analysts forecast the Connected Health M2M market in the US to grow at a CAGR of 34.34 percent over the period 2013-2018. Covered in this Report......
$2500

Global Database of the Top 1000 Pharmaceutical and Medicine Producers – Company Names, Financial Performance, Key Executives, and Contact Details

This company database offers valuable information on top 1000 pharmaceutical and medicine producers in the world which makes the database an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key company information in readily accessible and clearly presented format. The database is essential for companies who want to find out more about the leading players on the market or to find and contact potential customers and partners. This vital database contains the following information about the companies (when available): Company name Financial data Number of employees Contact details (address, phone, fax, email, web site) Names of the key executives Reasons to buy: - Know who are the major companies operat......
$1275

Global Database of the Top 1000 Medicinal and Botanical Producers – Company Names, Financial Performance, Key Executives, and Contact Details

This company database offers valuable information on top 1000 medicinal and botanical producers in the world which makes the database an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key company information in readily accessible and clearly presented format. The database is essential for companies who want to find out more about the leading players on the market or to find and contact potential customers and partners. This vital database contains the following information about the companies (when available): Company name Financial data Number of employees Contact details (address, phone, fax, email, web site) Names of the key executives Reasons to buy: - Know who are the major companies operating ......
$1275

Global Database of the Top 1000 Pharmaceutical Producers – Company Names, Financial Performance, Key Executives, and Contact Details

This company database offers valuable information on top 1000 pharmaceutical producers in the world which makes the database an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key company information in readily accessible and clearly presented format. The database is essential for companies who want to find out more about the leading players on the market or to find and contact potential customers and partners. This vital database contains the following information about the companies (when available): Company name Financial data Number of employees Contact details (address, phone, fax, email, web site) Names of the key executives Reasons to buy: - Know who are the major companies operating in the global market ......
$1275

Global Database of the Top 1000 Biological Product Producers – Company Names, Financial Performance, Key Executives, and Contact Details

This company database offers valuable information on top 1000 biological product producers in the world which makes the database an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key company information in readily accessible and clearly presented format. The database is essential for companies who want to find out more about the leading players on the market or to find and contact potential customers and partners. This vital database contains the following information about the companies (when available): Company name Financial data Number of employees Contact details (address, phone, fax, email, web site) Names of the key executives Reasons to buy: - Know who are the major companies operating in the global mar......
$1275

Global H1N1 Vaccines Market 2014-2018

H1N1 influenza (zoonotic) is an infectious disease in humans caused by a variant of the swine H1N1 virus, known as H1N1v virus. The H1N1v virus is a contagious virus which infects nose, throat, and lungs. H1N1 virus is an RNA virus belonging to the Orthomyxoviridae family. Influenza A viruses infect different animal species such as humans, swine, birds, seals, and horses. Influenza A viruses can be subdivided on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. Hemagglutinin component is used by the virus to bind to host cell receptors. This facilitates viral entry into the host cell. Neuraminidase protein enzymatically cleaves terminal sialic acid residues from mucins, thereby allowing the virus to reach underlying cells in the respiratory tract. Elde......
$2500

Global Pancreatic Cancer Market 2014-2018

Pancreatic cancer is a malignant cells form in the tissues of pancreas. Based on the initiation, pancreatic cancer can be classified into exocrine pancreatic cancer and endocrine pancreatic cancer. When pancreatic cancer cells spread from the pancreas to other parts of the body, it is known as metastatic pancreatic order. The incidence and mortality rate of pancreatic cancer is higher in men than in women. SEER estimates that there were 46,420 new pancreatic cancer cases recorded in the US in 2014. It also estimated that 39,590 deaths occurred in the US in 2014 as a result of pancreatic cancer, accounting for 6.8 percent of the total cancer deaths in the US. TechNavio's analysts forecast the Global Pancreatic Cancer market to grow at a CAGR of 10.70 percent over the period 2013-2018. ......
$2500